Goal of world market leader is not pie in the sky, founder says.
Tim Hunter Mon, 10 Sep 2018
Tauranga biotech company Honeylab is seeking further investment of up to $6 million as it prepares to commercialise two of its natural pharmaceutical products.
Nick Sandlant of Northington Partners, which is handling the capital raise, says the company’s preference is to bring in one or two
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly
credit card debit
Premium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly
credit card debit
Premium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly
credit card debit
Premium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly
credit card debit
